KNOWLEDGE OF, AND BEHAVIOR IN RESPONSE TO, COVID-19 PANDEMIC BY PREGNANT NIGERIAN IGBO WOMEN
DOI:
https://doi.org/10.61841/tphnpv31Keywords:
Knowledge, Behavior, COVID-19, Igbo, Pregnant women, NigeriaAbstract
BACKGROUND: The COVID-19 pandemic represents a foremost global contemporary public health challenge, with alarming death rate. Pregnant women by virtue of reduced immunity may be at increased risk of contracting the disease. OBJECTIVE: To elicit the knowledge of, and behavior, in response to the COVID-19 pandemic among pregnant Nigerian Igbo women.
SUBJECTS AND METHODS: Cross-sectional questionnaire-based study of 370 pregnant women from health facilities in Anambra state Nigeria, to elicit information on their knowledge of causes, mode of transmission, availability of vaccines, treatment modalities, and behavioral changes consequent on COVID-19. Data obtained was analyzed using SPSS IBM windows version 26.
RESULT: The modal age, parity and gestational age of the respondents were 25-29 years (49.2%); Para 1-4(89.5%) and <28 weeks (44.1%) respectively. Majority of the participants had tertiary education (54.1%) and of modal social class 5 (29.2%). All (100%) of the participants knew about covid-19; 91.4% recognized it was of viral aetiology; and 75.1% agreed it is an infectious disease. Indicated modes of transmission include air, droplets, faces, urine, dust, ingested foods, and drinks. Most of the participants recognized the unavailability of drugs (88.6%) and vaccine (80%) for COVID-19 management. Stated treatment modalities include symptomatic therapy; inhalation of steam from hot water, herbs, and roots; consumption of spices; antimalarial, antibiotics, multivitamins therapy; physical exercises; rest; and prayer. Majority of the respondents (67%) believed that COVID-19 had affected their general behavior and most adhered to COVID-19 safety measures - wearing of face mask; hand washing; use of hand-sanitizers and social distancing. The most common source of information to participants on COVID-19 was electronic media.
CONCLUSION: The knowledge of COVID-19 among the respondents was high and their behavior, satisfactory. There is need to maintain the public enlightenment tempo to sustain the good behavior in response to COVID-19 amongst pregnant women.
References
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it.
World Health Organization. Modes of transmission of virus causing COVID-19; implications for IPC precaution
recommendations.
Chan J, Yuan S, Kok K, To K, Chu H, et al (2020) A familial cluster of pneumonia associated with the 2019 novel
coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 395: 514-523.
Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, et al (2020) Characteristics of Women of Reproductive
Age with Laboratory-Confirmed SARS-COV-2 Infection by Pregnancy Status - United States, January 22- June 7,
MMWR Morb Mortal Wkly Rep 99: 769-775.
Centers for Disease Control and Prevention. Coronavirus Disease: People at Increased Risk And Other People Who
Need to Take Extra precautions.
Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, et al (2020) Clinical manifestations, risk factors, and maternal
and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ
: m3320.
Zhao X, Jang Y, Zhao Y, Xi H, Liu C, et al (2020) Analysis of the susceptibility to COVID-19 in pregnancy and
recommendations on potential drug screening. Eur J Clin Microbiol Infect Dis. 39: 1209-1220.
World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard.
Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). United States COVID-19 cases
and deaths by state.
Nigeria Centre for Disease Control. COVID-19 Case Update.
Centers for Disease control and prevention . Weekly COVID-19 Pregnancy Data.
Nwafor JI, Aniukwu JK , Anozie BO, Ikeotuonye AC, Okedo-Alex IN (2020) Knowledge and practice of preventive
measures against COVID-19 infection among pregnant women in a low-resource African setting. Int J
Gynecol/Obstet. 150: 121-123.
Anikwe CC, Ogah CO, Anikwe IH, Okorochukwu BC, Ikeoha CC (2020) Coronavirus disease 2019: Knowledge,
attitude and practice of pregnant women in a tertiary hospital in Abakiliki, southeast Nigeria. Int J Gynaecol Obstet.
: 197–202.
Olusanya O (1984) An original system of social classification for use in Nigeria and other developing countries. In:
th Annual Conference of the West African College of Surgeons Freetown, Sierra Leone.
Statistica. Poverty headcount rate in Nigeria as of 2019, by state [Internet].
Adinma JI, Okeke AO (1995) Contraception: awareness and practice amongst Nigerian tertiary school girls. West
Afr J Med. 14: 34-38.
Adinma JI, Nwosu BO (1995) Family planning knowledge and practice among Nigerian women attending an
antenatal clinic. Adv Contracept Off J Soc Adv Contracept. 11: 335-344.
Adinma JI, Okeke AO (1993) the pill: perceptions and usage among Nigerian students. Adv Contracept Off J Soc
Adv Contracept. 9: 341-349.
Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, et al (2020) Chloroquine and Hydroxychloroquine for
the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
Am J Trop Med Hyg. 102: 1184-1188.
World Health Organization. Effectiveness of the use of Chloroquine in COVID-19 case management.
Meo SA, Klonoff DC, Akram J (2020) Efficacy of Chloroquine and hydroxychloroquine in the treatment of COVID19. Eur Rev Med Pharmacol Sci 24: 4539-4547.
Chen Y, Shen T, Zhong L, Liu Z, Dong X, et al (2020) Research Progress of Chloroquine and Hydroxychloroquine
on the COVID-19 and their Potential Risks in Clinic use. Front Pharmacol. 11: 1167.
Yao X, Ye F, Zhang M, Cui C, Huang B, et al (2020) In vitro Antiviral Activity and Projection of Optimized Dosing
Design of Hydroxychlorquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV2). Clin Infect Dis 71: 732-739.
Andreani J, Le Bideau M, Duflot I, Jardot P, Rollanda C, et al (2020) In Vitro testing of combined hydroxychloroquine
and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020; 145: 104228.
Gaurtret P, Lagier JC, Parola P, Hoang VT, Meddeb L, et al (2020) Hydroxychloroquine and Azithromycin as a
treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 56: 105949.
Sarkar M, Woodland C, Koren G, Einarson AR (2006) Pregnancy outcome following gestational exposure to
azithromycin. BMC Pregnancy Childbirth. 6: 18.
Bar-Oz B, Weber-Schoendorfer C, Berlin M, Clementi M, Gianantonio E, et al (2012) The outcomes of pregnancy in
women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Drug saf.
: 589-598.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
